中文
← Back to Markets

European Union

Closed

Europe · As of 2026-02-20

China is not listed as an approved third country for egg product exports to the EU under Commission Implementing Regulation (EU) 2021/405 (Annex -I). China also lacks an approved residue monitoring plan for eggs under Decision 2011/163/EU. This is a structural barrier requiring multi-year regulatory process to resolve.

Market Access Overview

The European Union maintains one of the world’s most restrictive food import frameworks for products of animal origin. For egg products, China is not listed as an approved third country, which means commercial export of egg products from China to the EU is not legally possible.

This is a structural barrier, not a temporary restriction — it requires formal regulatory process changes at the EU level to resolve, typically taking 5–10 years.

Recent development: Regulation (EU) 2025/354 (March 2025) added Brazil and Thailand to the approved list for eggs — China was not included.

How EU Import Authorization Works

EU imports of products of animal origin follow a three-layer authorization system:

LayerRequirementLegal Basis
1. Country listingThe exporting country must be on the EU’s approved third-country list for the specific product categoryRegulation (EU) 2017/625; Commission Implementing Regulation (EU) 2021/405
2. Establishment listingIndividual production facilities must be approved and listed in TRACES-NTRegulation (EC) No 853/2004, Article 12
3. Certificate modelEach shipment requires a health certificate in EU-prescribed format, signed by the country’s competent authorityCommission Implementing Regulation (EU) 2020/2235

China fails at Layer 1 — it is not on the approved list, so Layers 2 and 3 are moot.

Specific Regulations

Commission Implementing Regulation (EU) 2021/405 establishes the lists of third countries authorized to export specific categories of animal products to the EU.

Residue Monitoring Plan Prerequisite

A prerequisite for third-country listing is having an approved residue monitoring plan under Decision 2011/163/EU. The Decision’s Annex marks approved countries with an “X” for each animal product category.

  • China has approved plans for certain categories (aquaculture, honey, poultry meat)
  • China does NOT have approval for the “eggs” category
  • This is a separate barrier that must be resolved before third-country listing can proceed
  • Decision 2011/163/EU (consolidated): https://eur-lex.europa.eu/eli/dec/2011/163(1)/2022-08-11/eng
RegulationTitleRelevance
Regulation (EC) No 852/2004General hygiene of foodstuffsBaseline hygiene requirements for all food
Regulation (EC) No 853/2004Specific hygiene rules for food of animal originEgg product-specific processing standards (Section X, Chapter II)
Regulation (EU) 2017/625Official controls on food and feedFramework for third-country audits and import checks
Commission Implementing Regulation (EU) 2020/2235Model health certificatesPrescribes exact certificate formats for each product category

Establishment Listing (TRACES-NT)

Even if a country IS listed as an approved third country, each individual establishment must also be approved and listed in the EU’s TRACES-NT system:

  1. The third country’s competent authority evaluates and proposes establishments for listing
  2. The establishment list is submitted via the Establishment Lists module in TRACES-NT (operational since 1 December 2021)
  3. The European Commission checks the details and publishes the list
  4. Each establishment receives a unique approval number

Since China is not listed for eggs, no Chinese egg product establishments can be listed in TRACES for this category.

EU MRL Regulations

If market access were eventually obtained, egg products would need to comply with two key MRL frameworks:

Pesticide MRLs — Regulation (EC) No 396/2005

Veterinary Drug MRLs — Regulation (EU) No 37/2010

What Would Be Required to Change Status

For China to gain EU market access for egg products, the following steps would be necessary:

Step 1: Formal Application

China’s competent authority (GACC) would need to formally request the European Commission (DG SANTE) to initiate the approval process for egg products.

Step 2: Residue Monitoring Plan Approval

Under Decision 2011/163/EU and Regulation (EU) 2017/625, the exporting country must submit a National Residue Control Plan covering:

  • Veterinary drug residues in eggs
  • Environmental contaminants
  • Prohibited substances monitoring
  • The plan must be assessed as equivalent to EU requirements

Step 3: DG SANTE Audit Mission

The European Commission’s Health and Food Audits and Analysis Directorate (formerly FVO, now part of DG SANTE) conducts on-site audit missions to assess:

  • Performance of the country’s food safety authorities
  • Organization of national controls
  • Effectiveness of controls in food production establishments
  • Laboratory capabilities and accreditation
  • Residue monitoring program implementation
  • HPAI and other disease surveillance
  • Traceability and recall systems

DG SANTE Audits page: https://food.ec.europa.eu/horizontal-topics/official-controls-and-enforcement/health-and-food-audits-and-analysis_en Audit Reports Database: https://food.ec.europa.eu/horizontal-topics/official-controls-and-enforcement/health-and-food-audits-and-analysis/annual-reports_en Country Profiles: https://ec.europa.eu/food/audits-analysis/country_profiles/index.cfm

Step 4: Equivalence Determination

DG SANTE must determine that China’s food safety system for egg products provides equivalent guarantees to EU standards. This is a political and technical process involving:

  • Standing Committee on Plants, Animals, Food and Feed (SCoPAFF) deliberation
  • All 27 EU member states must agree
  • Process typically takes 3–7 years from initiation

Step 5: Individual Establishment Listing

Even after country listing, each individual facility must be separately approved:

RASFF History

The EU’s Rapid Alert System for Food and Feed (RASFF) has recorded alerts involving Chinese egg products:

Confirmed Alert

  • Notification 2024.7729 (22 October 2024): Detection of enrofloxacin (a fluoroquinolone antibiotic) in fresh eggs originating from China. Classified as an urgent notification. Enrofloxacin is banned in food-producing animals in the EU due to antimicrobial resistance concerns.

Broader Context

  • Total egg/egg product RASFF notifications (2000–2022): 434
  • Top hazard categories: pathogenic microorganisms (40.78%), pesticide residues (27.88%), veterinary drug residues (7.37%)
  • 2017 was the peak year (126 notifications), driven by the fipronil contamination scandal
  • These alerts contribute to institutional resistance to expanding China’s product authorization scope

RASFF Portal: https://webgate.ec.europa.eu/rasff-window/screen/search RASFF Overview: https://food.ec.europa.eu/food-safety/rasff_en

Regulatory Authorities

AuthorityRoleWebsite
European Commission — DG SANTEThird-country listing, audit missions, equivalenceec.europa.eu/food
EFSA (European Food Safety Authority)Scientific risk assessmentwww.efsa.europa.eu
RASFFIncident tracking, border notificationsRASFF Portal
SCoPAFFMember state voting on food safety measuresEC committees
EMA (European Medicines Agency)Veterinary drug MRL settingwww.ema.europa.eu

Risk Notes

  • Do not plan EU exports as a near-term strategy — the structural barriers are unlikely to change within a 1–5 year horizon
  • Two prerequisite barriers: China lacks BOTH the residue monitoring plan approval (Decision 2011/163) AND the third-country listing (Reg 2021/405) for eggs
  • No indication of active progress — there is no publicly available evidence that China has initiated the formal application process for egg products
  • RASFF alert 2024.7729 (enrofloxacin in Chinese eggs) reinforces institutional caution
  • EU regulatory decisions are consensus-driven among 27 member states — any single member can raise objections
  • Post-Brexit UK operates a separate import framework but has similar high standards — China is not listed for egg products there either

Strategic Considerations

  • Monitor DG SANTE audit reports and third-country list updates
  • Build domestic compliance capability to EU-equivalent standards (Regulation (EC) No 853/2004) as a long-term investment
  • Focus resources on accessible markets (HK/Macau, Singapore, Southeast Asia) while tracking EU developments
  • Track residue monitoring plan submissions — this is the first step that would signal progress

Sources

Regulations & Legal Basis

MRL Databases

DG SANTE & Audit

TRACES & Establishments

RASFF

Other